These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Penetrating the conjunctival barrier. The role of molecular weight. Kahn M; Barney NP; Briggs RM; Bloch KJ; Allansmith MR Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):258-61. PubMed ID: 2303328 [TBL] [Abstract][Full Text] [Related]
6. Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat. Trocmé SD; Bonini S; Barney NP; Bloch KJ; Allansmith MR Acta Ophthalmol (Copenh); 1988 Feb; 66(1):24-32. PubMed ID: 3364167 [TBL] [Abstract][Full Text] [Related]
7. Late-phase reaction in topically induced ocular anaphylaxis in the rat. Trocmé SD; Bonini S; Barney NP; Bloch KJ; Allansmith MR Curr Eye Res; 1988 May; 7(5):437-43. PubMed ID: 3136973 [TBL] [Abstract][Full Text] [Related]
8. Participation of ocular tissues in systemic anaphylaxis. Allansmith MR; Bloch KJ; Baird RS; Sinclair KJ Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):690-4. PubMed ID: 7380627 [TBL] [Abstract][Full Text] [Related]
9. Morphologic evidence that compound 48/80-challenged rat eyelid mast cells differ in their states of maximal degranulation. Allansmith MR; Baird RS; Ross RN Ophthalmic Res; 1989; 21(3):206-15. PubMed ID: 2476697 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Calonge MC; Pastor JC; Herreras JM; González JL Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):176-80. PubMed ID: 2105283 [TBL] [Abstract][Full Text] [Related]
13. Dark-staining bodies in the conjunctival epithelium of rats after multiple topical challenges with compound 48/80. Allansmith MR; Baird RS; Ross RN Ann Ophthalmol; 1988 Jul; 20(7):264-6, 270. PubMed ID: 2460012 [TBL] [Abstract][Full Text] [Related]
14. Intestinal anaphylaxis induces Fos immunoreactivity in myenteric plexus of rat small intestine. Miampamba M; Tan DT; Oliver MR; Sharkey KA; Scott RB Am J Physiol; 1997 Jan; 272(1 Pt 1):G181-9. PubMed ID: 9038892 [TBL] [Abstract][Full Text] [Related]
16. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Allansmith MR; Baird RS; Ross RN; Barney NP; Bloch KJ Acta Ophthalmol Suppl (1985); 1989; 192():145-53. PubMed ID: 2554644 [TBL] [Abstract][Full Text] [Related]
17. Effect of locally induced intestinal anaphylaxis on the uptake of a bystander antigen. Bloch KJ; Walker WA J Allergy Clin Immunol; 1981 Apr; 67(4):312-6. PubMed ID: 7204787 [TBL] [Abstract][Full Text] [Related]
18. Vascular permeability during the early and late phases of ocular anaphylaxis. Calonge M; Ng B; Allansmith MR; Bloch KJ Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):55-9. PubMed ID: 1730548 [TBL] [Abstract][Full Text] [Related]
19. Epithelial response to intestinal anaphylaxis in rats: goblet cell secretion and enterocyte damage. Perdue MH; Forstner JF; Roomi NW; Gall DG Am J Physiol; 1984 Dec; 247(6 Pt 1):G632-7. PubMed ID: 6507619 [TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]